Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial

OBJECTIVES: To determine the efficacy of adding abacavir (Ziagen, ABC) to optimal stable background antiretroviral therapy (SBG) to AIDS dementia complex (ADC) patients and address trial design. DESIGN: Phase III randomized, double-blind placebo-controlled trial. SETTING: Tertiary outpatient clinics...

Descripción completa

Detalles Bibliográficos
Autores principales: Brew, Bruce J, Halman, Mark, Catalan, Jose, Sacktor, Ned, Price, Richard W, Brown, Steve, Atkinson, Hamp, Clifford, David B, Simpson, David, Torres, Gabriel, Hall, Colin, Power, Christopher, Marder, Karen, Arthur, Justin C. Mc, Symonds, William, Romero, Carmen
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1845158/
https://www.ncbi.nlm.nih.gov/pubmed/17401456
http://dx.doi.org/10.1371/journal.pctr.0020013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1845158/
https://www.ncbi.nlm.nih.gov/pubmed/17401456
http://dx.doi.org/10.1371/journal.pctr.0020013

Ejemplares similares